share_log

Wedbush:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由51.00美元调整至50.00美元。

Zhitong Finance ·  May 10 09:26

Wedbush:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由51.00美元调整至50.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment